T Rowe PR Health Science-InvPRHSX
13F holders, Q1 2025 (March 31)4holders −1
0new positions
1sold out
$79.04avg. 13F price*
At the end of Q1 2025, 4 institutions reported holding T Rowe PR Health Science-Inv (PRHSX) in their 13F filings, down 1 from Q4 2024. 0 opened new positions and 1 sold out. The largest holders were Ethos Financial Group, LLC ($203K), Westside Investment Management, Inc. ($114K) and Coston, McIsaac & Partners ($56K).
- Company
- T Rowe PR Health Science-Inv
- CUSIP
- 741480107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $2K |
All 13F filers, Q4 2024 → Q1 2025: 280 shares sold, net −280 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Ethos Financial Group, LLC | 0.02% | No change | 2,555 | $203K |
| Westside Investment Management, Inc. | 0.02% | No change | 1,467 | $114K |
| Coston, McIsaac & Partners | 0.02% | Reduce -26.1% | 706 | $56K |
| Financial Gravity Asset Management, Inc. | 0.00% | — | 109 | $9K |
"% of holder's portfolio" is PRHSX's weight in each manager's 13F, not the share of T Rowe PR Health Science-Inv the manager owns.